Changes of Serum Soluble Receptor Activator for Nuclear Factor-κB Ligand after Glucocorticoid Therapy Reflect Regulation of Its Expression by Osteoblasts

CONTEXT: Osteoporosis is a serious complication of systemic glucocorticoid therapy. The role of serum soluble receptor activator for nuclear factor-κB ligand (RANKL) in glucocorticoid-induced osteoporosis remains unclear. OBJECTIVE: The objective of the study was to clarify the influence of serum so...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kaneko, Kaichi, Kusunoki, Natsuko, Hasunuma, Tomoko, Kawai, Shinichi
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2012
Assuntos:
Hot Topics in Translational Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3462941/
https://ncbi.nlm.nih.gov/pubmed/22791764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-1971
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados